CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Fresenius Kabi USA LLC v. Dr. Reddy's Laboratories Ltd.

1:13-cv-00925

Overview

Case Number 1:13-cv-00925
Filing Date 2013-05-23
Status Terminated
Termination Date 2014-09-08
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Dr. Reddy's Laboratories Inc. Operating Company

Represented By

2 Attorneys Listed

Frank D. Rodriguez

Email: frodriguez@windelsmarx.com

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Counter Claimant

Fresenius Kabi USA LLC Operating Company

Represented By

8 Attorneys Listed

Todd Marabella

Email: tmarabella@goodwinlaw.com

Sundar Subramanyam

Email: ssubramanyam@goodwinprocter.com

Samuel Sherry

Law Office of Michael R. Abram

115 South Bedford Street, Georgetown, DE 19947

Laurie S. Gill

Email: lgill@goodwinprocter.com

John T. Bennett

Law Office of Michael R. Abram

115 South Bedford Street, Georgetown, DE 19947

Jennifer L. Ford

Email: jford@goodwinprocter.com

Daryl L. Wiesen

Email: dwiesen@goodwinlaw.com

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Dr. Reddy's Laboratories Ltd. Operating Company

Represented By

3 Attorneys Listed

Dmitry V. Shelhoff

Email: dshelhoff@pergamentcepeda.com

Alan H. Pollack

Email: apollack@windelsmarx.com

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 18 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (18): πŸ‡¨πŸ‡¦ Canada πŸ‡©πŸ‡ͺ Germany πŸ‡ͺπŸ‡Ί Europe FR GB πŸ‡―πŸ‡΅ Japan πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5714520
Propofol compostion containing edetate
Filed: 1995-03-22
Issued: 1998-02-03
Expired (Term Ended)
Expires: 2015-03-22
US5731355
Pharmaceutical compositions of propofol and edetate
Filed: 1997-02-18
Issued: 1998-03-24
Expired (Term Ended)
Expires: 2017-02-18
US5731356
Pharmaceutical compositions of propofol and edetate
Filed: 1997-02-18
Issued: 1998-03-24
Expired (Term Ended)
Expires: 2017-02-18
US5908869
Propofol compositions containing edetate
Filed: 1998-01-30
Issued: 1999-06-01
Expired (Term Ended)
Expires: 2018-01-30

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

6

Dispositive

0

Granted

1

Denied

1

Pending / Review

4

Motions by Category

Procedural / Extension Motion 5 Motion to Compel Discovery 1

Key Dispositive Motions & Rulings

Motion to Compel Discovery Granted
ORDER Granting Plaintiffs Letter/Motion to Compel (see D.I. 48 & 49 in 13-cv-00925-RGA, and 57 & 59 in 1:13-cv-01015-RGA). Signed by Judge Richard G. Andrews on...
Entry #50 • 2014-03-18 Document →
Procedural / Extension Motion Denied
ORDER Denying (D.I. 18 in 13-cv-00925-RGA, D.I. 17 in 13-cv-01015-RGA) MOTION For Leave to File Amended Complaint, filed by Fresenius Kabi USA, LLC. Signed by J...
Entry #45 • 2014-03-10 Document →
Procedural / Extension Motion Pending / Under Review
REPLY BRIEF re 18 MOTION to Amend/Correct Complaint filed by Fresenius Kabi USA LLC. (Farnan, Brian) (Entered: 09/26/2013)
Entry #26 • 2013-09-26 Document →
Procedural / Extension Motion Pending / Under Review
ANSWERING BRIEF in Opposition re 18 MOTION to Amend/Correct Complaint filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..Reply Brief due date...
Entry #25 • 2013-09-16 Document →
Procedural / Extension Motion Pending / Under Review
MOTION to Amend/Correct Complaint - filed by Fresenius Kabi USA LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Farnan, Brian) (Entered: 08/30/2013)
Entry #18 • 2013-08-30 Document →
Procedural / Extension Motion Pending / Under Review
OPENING BRIEF in Support re 18 MOTION to Amend/Correct Complaint filed by Fresenius Kabi USA LLC.Answering Brief/Response due date per Local Rules is 9/16/2013....
Entry #19 • 2013-08-30 Document →

Docket Entries

(90 total)
Pleading / Complaint

COMPLAINT - filed against Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1295756.) - filed by Fresenius Kabi USA LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(mdb) (Entered: 05/24/2013)

Entry #1 • 2013-05-23
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (mdb) (Entered: 05/24/2013)

Entry #2 • 2013-05-23
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/12/13. Date of Expiration of Patent: 9/22/15.Thirty Month Stay Deadline: 10/12/2015. (mdb) (Entered: 05/24/2013)

Entry #3 • 2013-05-23
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,714,520; 5,731,355; 5,731,356; 5,908,869;. (mdb) (Entered: 05/24/2013)

Entry #4 • 2013-05-23
1

Disclosure Statement pursuant to Rule 7.1 filed by Fresenius Kabi USA LLC identifying Corporate Parent Fresenius Kabi USA Inc., Other Affiliate Fresenius Kabi Pharmaceuticals Holding Inc., Other Affiliate Fresenius Kabi AG, Other Affiliate Fresenius SE & Co. KGaA for Fresenius Kabi USA LLC. (mdb) (Entered: 05/24/2013)

Entry #5 • 2013-05-23
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc